Search

everythinglearnresearchcommunity

for

Search:↓

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Androgens significantly affect female hair loss, and hormonal treatments may help.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Obese women with PCOS are more likely to have fatty liver disease.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.